Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06632158 · ClinicalTrials.gov registry record · Phase 2
Personal Relevance of Psychotherapy for Asian Americans
A Phase 2 study of Anxiety and Stress, sponsored by IRIS Media.
- Completed
- Registry status
- Phase 2
- Development phase
- 268
- Enrollment target
- 1
- Study location
NCT06632158: Completed Phase 2 study of Anxiety and Stress, sponsored by IRIS Media.
NCT06632158 is a Phase 2 study of Anxiety and Stress that has completed, run by IRIS Media. The registered enrollment target is 268 participants, below the 439-participant average among 364 other Anxiety trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06632158, a Phase 2 study of Anxiety and Stress, has completed, sponsored by IRIS Media.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 268 participants
- Enrollment target
- 1
- Study location
Study Summary
Using a three-armed design the investigators will test whether participants in the Mindboba online application experience significantly greater improvements as compared to participants in the active control (online app based on Cognitive Behavioral Therapy) and participants in the business-as-usual control. The outcome measures are self-reported social problem-solving, self-efficacy, stress, depression, anxiety, attitudes towards seeking mental health, and knowledge.
Primary Outcome
Self-efficacy will be measured using the Mental Health Self-Efficacy Scale (MHSES),127 a 6-item Likert-type single-factor scale measuring one's capability to perform behaviors related to mental health. The MHSES has demonstrated good internal reliability (alpha = .89) and is positively correlated with work, social adjustment, and emotional stability, and negatively correlated with measures of depression. The reported data uses the average of the 6 items on the scale with a possible range of 1 t
Interventions
- BEHAVIORAL MindBoba
- BEHAVIORAL Mindshift CBT
Study Locations (1)
Oregon
- IrisEd dba Trifoia - Eugene
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 268 participants |
| Start Date | 2024-05-01 |
| Est. Completion | 2024-12-30 |
| Phase | Phase 2 |
What the finished NCT06632158 record still lists
NCT06632158 is an interventional study that assigns participants to a tested intervention. The registered 268 participants enrollment target is mid-sized for trials with a published cap, below the 439-participant average among 364 other Anxiety trials with a reported enrollment target (39% lower).
The record links to 3 conditions, with Anxiety appearing as the primary indexed condition, and to 2 interventions - of which MindBoba is the first listed.
NCT06632158 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT06632158 about?
NCT06632158 is a clinical study titled "Personal Relevance of Psychotherapy for Asian Americans". Using a three-armed design the investigators will test whether participants in the Mindboba online application experience significantly greater improvements as compared to participants in the active control (online app based on Cognitive Behavioral Therapy) and participants in the business-as-usual ...
What is the current status of trial NCT06632158?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 268 participants. The study started on 2024-05-01. Estimated completion is 2024-12-30.
What conditions does trial NCT06632158 study?
This clinical trial studies the following conditions: Anxiety, Stress, Behavior.
What interventions are being tested in trial NCT06632158?
The interventions under investigation include: MindBoba (BEHAVIORAL), Mindshift CBT (BEHAVIORAL).
Who is sponsoring clinical trial NCT06632158?
This trial is sponsored by IRIS Media, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06632158 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06632158's enrollment target sits among peer trials
268 66th of 364 higher than 299 of 364 other Anxiety trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women
RECRUITING · Phase 2
-
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors
RECRUITING · Phase 2
-
Personalized Brain Stimulation to Treat Chronic Concussive Symptoms
RECRUITING · Phase 2
-
Cannabidiol and Older Adult Cannabis Users
RECRUITING · Phase 2
-
Use of CBD in the Treatment of Anxiety
RECRUITING · Phase 2
-
Cannabis for Palliative Care in Cancer
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05000632 · 268 participants · NA
Smoke Free SafeCare: Establishing a Smoke Free Home in CPS-involved Families
- NCT05797831 · 268 participants · Phase 2
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
- NCT05997381 · 268 participants · NA
BioBrace® Implant for Arthroscopic Repair of Full Thickness Rotator Cuff Tears
- NCT06233461 · 268 participants · Phase 2
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI